DENVILLE, N.J., March 11, 2009 -- Lantis Laser Inc. (Pink Sheets:LLSR) (http://www.lantislaser.com), announced today that its President & CEO, Mr. Stan Baron, can be heard all this week on the AOL Small Cap Show produced by AGORACOM Investor Relations.
Mr. Baron will be discussing the company's latest developments including making the transition from the Pink Sheets to the OTCBB; the timing of commercial rollout of its OCT (Optical Coherence Tomography) and NIR (Near Infrared Transillumination) products, and how OCT/NIR will impact the dental industry.
The interview can be accessed two ways. For those who are AOL subscribers, simply go to AOL and enter the key words "small cap." For those who are not AOL subscribers, the interview can be accessed on the Broadcast Center with AGORACOM at http://agoracom.com/broadcastcenter.
Lantis Laser has worldwide rights to market OCT and NIR to the dental industry. These light-based modalities represent a breakthrough in dental imaging and provide higher resolution and more detailed and accurate diagnosis than the standard dental x-ray with no radiation. OCT technology is currently used in ophthalmology and cardiovascular imaging with other applications under research and development. The total market potential for OCT/NIR in dentistry is estimated at $5 Billion, at retail.
About Lantis Laser
Lantis was formed to commercialize the application of novel technologies in the dental industry. The criteria for selected products include competitive edge, exclusivity and large market potential. Lantis has rights to the application of OCT technology in the field of dentistry under its license Agreements with Lawrence Livermore National Laboratory (exclusive) and LightLab Imaging (non-exclusive). Lantis also has exclusive rights to MEMS scanning technology from the University of Florida. The Company has an exclusive license with The Regents of the University of California for the Near-infrared Imaging TransilluminationTechnology and an exclusive development and supply Agreement with Axsun Technologies for its advanced OCT Engine. OCT was invented in the early 1990's at the Massachusetts Institute of Technology and is currently being commercialized in ophthalmology, cardiovascular imaging and other bio-medical applications including optical biopsies and cancer detection.
To find out more about Lantis Laser (Pink Sheets:LLSR), visit our website at www.lantislaser.com
Safe Harbor: Statements regarding financial matters in this press release other than historical facts are "forward-looking statements" within the meaning of section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The company intends that such statements about the Company's future expectations, including future revenues and earnings, technology efficacy and all other forward-looking statements be subject to the safe harbors created thereby. The Company is a development stage company who continues to be dependent upon outside capital to sustain its existence. Since these statements (future operational results and sales) involve risks and uncertainties and are subject to change at any time, the Company's actual results may differ materially from expected results.
CONTACT: Lantis Laser Inc.
Corporate Inquiries:
Stan Baron, President & CEO
(203) 300-7622
sbaron@lantislaser.com
AGORACOM Investor Relations
http://www.agoracom.com/IR/lantislaser
llsr@agoracom.com
OCT News:
www.octnews.org
